Matrix Metalloproteinases and Their Inhibitors in Pediatric Severe Acute Pancreatitis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Feb 14

PMID 35157709

Authors

David S Vitale

Patrick Lahni

Lindsey Hornung

Tyler Thompson

Peter R Farrell

Tom K Lin

Jaimie D Nathan

Hector R Wong

Maisam Abu-El-Haija

Affiliations

Soon will be listed here.

Abstract

Background: Acute pancreatitis (AP) is increasing in incidence in adult and pediatric patients. Identification of patients at high risk for progression to severe acute pancreatitis (SAP) is crucial, as it can lead to increased mortality and health system cost. Matrix metalloproteinases (MMPs) are endopeptidases which degrade extracellular matrix proteins and increase activity of pro-inflammatory cytokines. Tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity. Prior limited studies of MMPs and TIMPs have found some to be associated with development of SAP. The aim of this study was to further investigate the role of MMPs and TIMPs in detecting pediatric patients at risk for developing moderately severe AP or SAP.

Methods: Plasma samples were prospectively collected for patients <21 years of age presenting with AP between November 2015 and October 2019, along with healthy controls. Bead-based multiplex assays were utilized to test levels of 12 MMPs and TIMPs.

Results: Samples were collected from 7 subjects who developed SAP, 7 with moderately severe AP, 45 with mild AP and 44 healthy controls. MMP-9 (p = 0.04) and TIMP-1 (p = 0.01) levels were significantly higher in SAP patients. A multivariable logistic regression model using MMP-9 and TIMP-1 predicted SAP (AUROC 0.87, 95% CI 0.76-0.98).

Conclusion: We have demonstrated that MMP9 and TIMP1 levels are increased at AP presentation in pediatric patients who developed SAP during the course of illness. Further studies are needed to validate the use of MMPs and TIMPs as predictive tools for development of SAP in pediatric pancreatitis.

Citing Articles

Chaihuang Qingfu Pills Protect Against Acute Pancreatitis-Associated Acute Lung Injury Through MMP9-NLRP3-Pyroptosis Pathway.

Xiao W, Shi H, Tian Y, Chen F, Xie Y, Han X J Inflamm Res. 2025; 18:2317-2338.

PMID: 39991664 PMC: 11846512. DOI: 10.2147/JIR.S501531.

Overview of the cellular and immune mechanisms involved in acute pancreatitis: In search of new prognosis biomarkers.

Mititelu A, Grama A, Colceriu M, Pop T, Pop T Expert Rev Mol Med. 2025; 27:e9.

PMID: 39757373 PMC: 11879381. DOI: 10.1017/erm.2024.40.

Gene Regulation of Neutrophils Mediated Liver and Lung Injury through NETosis in Acute Pancreatitis.

Liu X, Zheng Y, Meng Z, Wang H, Zhang Y, Xue D Inflammation. 2024; 48(1):393-411.

PMID: 38884700 DOI: 10.1007/s10753-024-02071-w.

The Predictive Value of Serum DAO, HDC, and MMP8 for the Gastrointestinal Injury in the Early Stage of Acute Pancreatitis in an Animal Model and a Clinical Study.

Cheng R, Wang J, Wu Q, Peng P, Liao G, Luo X Int J Gen Med. 2024; 17():1937-1948.

PMID: 38736673 PMC: 11088402. DOI: 10.2147/IJGM.S461352.

References

Morinville V, Husain S, Bai H, Barth B, Alhosh R, Durie P . Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr. 2012; 55(3):261-5. PMC: 3626452. DOI: 10.1097/MPG.0b013e31824f1516. View

Orkin S, Trout A, Fei L, Lin T, Nathan J, Thompson T . Sensitivity of Biochemical and Imaging Findings for the Diagnosis of Acute Pancreatitis in Children. J Pediatr. 2019; 213:143-148.e2. PMC: 6765403. DOI: 10.1016/j.jpeds.2019.06.028. View

Hsu A, Barrett C, DeBusk G, Ellson C, Gautam S, Talmor D . Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress Syndrome. Shock. 2015; 44(2):128-36. PMC: 4830084. DOI: 10.1097/SHK.0000000000000386. View

Suzuki M, Saito N, Naritaka N, Nakano S, Minowa K, Honda Y . Scoring system for the prediction of severe acute pancreatitis in children. Pediatr Int. 2014; 57(1):113-8. DOI: 10.1111/ped.12449. View

Aynaci M, Tuncyurek P, Nart D, Zeytunlu M, Ozutemiz O, Ersoz G . Does matrix metalloproteinase activity predict severity of acute pancreatitis?. ANZ J Surg. 2006; 76(9):801-4. DOI: 10.1111/j.1445-2197.2006.03871.x. View

Morinville V, Barmada M, Lowe M . Increasing incidence of acute pancreatitis at an American pediatric tertiary care center: is greater awareness among physicians responsible?. Pancreas. 2009; 39(1):5-8. DOI: 10.1097/MPA.0b013e3181baac47. View

Vitale D, Hornung L, Lin T, Nathan J, Prasad S, Thompson T . Blood Urea Nitrogen Elevation Is a Marker for Pediatric Severe Acute Pancreatitis. Pancreas. 2019; 48(3):363-366. PMC: 8579319. DOI: 10.1097/MPA.0000000000001265. View

Fic P, Zakrocka I, Kurzepa J, Stepulak A . [Matrix metalloproteinases and atherosclerosis]. Postepy Hig Med Dosw (Online). 2011; 65:16-27. DOI: 10.5604/17322693.931536. View

Farrell P, Hornung L, Farmer P, DesPain A, Kim E, Pearman R . Who's at Risk? A Prognostic Model for Severity Prediction in Pediatric Acute Pancreatitis. J Pediatr Gastroenterol Nutr. 2020; 71(4):536-542. PMC: 8020899. DOI: 10.1097/MPG.0000000000002807. View

10.

Abu-El-Haija M, Kumar S, Szabo F, Werlin S, Conwell D, Banks P . Classification of Acute Pancreatitis in the Pediatric Population: Clinical Report From the NASPGHAN Pancreas Committee. J Pediatr Gastroenterol Nutr. 2017; 64(6):984-990. DOI: 10.1097/MPG.0000000000001583. View

11.

Guo J, Xue P, Yang X, Liu X, Huang W, Xia Q . Serum matrix metalloproteinase-9 is an early marker of pancreatic necrosis in patients with severe acute pancreatitis. Hepatogastroenterology. 2011; 59(117):1594-8. DOI: 10.5754/hge11563. View

12.

Hornung L, Szabo F, Kalkwarf H, Abu-El-Haija M . Increased Burden of Pediatric Acute Pancreatitis on the Health Care System. Pancreas. 2017; 46(9):1111-1114. PMC: 8147872. DOI: 10.1097/MPA.0000000000000918. View

13.

Keck T, Balcom 4th J, Fernandez-Del Castillo C, Antoniu B, Warshaw A . Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology. 2002; 122(1):188-201. DOI: 10.1053/gast.2002.30348. View

14.

Ling L, Li Y, Li H, Li W, Zhang H . MMP-2 and MMP-9 gene polymorphisms act as biological indicators for ulinastatin efficacy in patients with severe acute pancreatitis. Medicine (Baltimore). 2019; 98(24):e15831. PMC: 6587626. DOI: 10.1097/MD.0000000000015831. View

15.

Mikami Y, Dobschutz E, Sommer O, Wellner U, Unno M, Hopt U . Matrix metalloproteinase-9 derived from polymorphonuclear neutrophils increases gut barrier dysfunction and bacterial translocation in rat severe acute pancreatitis. Surgery. 2009; 145(2):147-56. DOI: 10.1016/j.surg.2008.08.036. View

16.

Abu-El-Haija M, Lin T, Palermo J . Update to the management of pediatric acute pancreatitis: highlighting areas in need of research. J Pediatr Gastroenterol Nutr. 2014; 58(6):689-93. DOI: 10.1097/MPG.0000000000000360. View

17.

Brumann M, Kusmenkov T, Ney L, Kanz K, Leidel B, Biberthaler P . Concentration kinetics of serum MMP-9 and TIMP-1 after blunt multiple injuries in the early posttraumatic period. Mediators Inflamm. 2012; 2012:435463. PMC: 3321737. DOI: 10.1155/2012/435463. View

18.

Szabo F, Fei L, Alfaro Cruz L, Abu-El-Haija M . Early Enteral Nutrition and Aggressive Fluid Resuscitation are Associated with Improved Clinical Outcomes in Acute Pancreatitis. J Pediatr. 2015; 167(2):397-402.e1. DOI: 10.1016/j.jpeds.2015.05.030. View

19.

Parniczky A, Abu-El-Haija M, Husain S, Lowe M, Oracz G, Sahin-Toth M . EPC/HPSG evidence-based guidelines for the management of pediatric pancreatitis. Pancreatology. 2018; 18(2):146-160. DOI: 10.1016/j.pan.2018.01.001. View

20.

Sri Manjari K, Jyothy A, Vidyasagar A, Prabhakar B, Nallari P, Venkateshwari A . Matrix metalloproteinase-9, transforming growth factor-β1, and tumor necrosis factor-α plasma levels in chronic pancreatitis. Indian J Gastroenterol. 2013; 32(2):103-7. DOI: 10.1007/s12664-012-0299-5. View